HALDER NSE filing

Halder Venture Board Approves Auditor Changes, Capital Increase & Warrant Issue

The RealCase readMedium impact Positive

Halder Venture's board approved the appointment of M/s J Kumar Jain & Associates as internal auditor and accepted the resignation of M/s Somnath Ray & Associates. The company will increase its authorized share capital from ₹13.42 crore to ₹18.42 crore and issue 7,93,650 warrants at ₹315 each, totaling ₹24.99 crore, subject to shareholder approval.

Why it matters

The appointment of a new auditor is a routine procedural change. However, the increase in authorized share capital and the issuance of convertible warrants represent a potential equity fundraising event that could impact the company's financial structure and future shareholding pattern.

The market read

The company is undertaking significant corporate actions including auditor changes, capital increase, and issuance of warrants, which are generally viewed positively as they can support future growth and operational efficiency.

Halder Venture Limited's Board of Directors convened on March 26, 2026, to discuss and approve several key resolutions. The board accepted the resignation of the company's internal auditor, M/s Somnath Ray & Associates, citing preoccupation as the reason for their departure. Subsequently, M/s J Kumar Jain & Associates has been appointed as the new internal auditor for the Financial Year 2025-2026.

In a significant move to bolster its capital structure, the company's board has also approved an increase in its authorized share capital. The authorized capital will be raised from ₹13.42 crore to ₹18.42 crore by creating an additional 50,00,000 equity shares of ₹10 each. This change is subject to shareholder approval via postal ballot.

Furthermore, the board has approved the creation, issue, and offer of up to 7,93,650 convertible warrants, each with a face value of ₹10 and an issue price of ₹315, to specified persons. These warrants are convertible into one fully paid-up equity share of the company. The total value of this warrant issuance is approximately ₹24.99 crore, with P.K. Bio Link Private Limited being the proposed allottee for the entire 7,93,650 warrants. This issuance also requires shareholder approval through postal ballot. The company will proceed with seeking shareholder consent via a postal ballot notice.

Filing to action

What to do with a filing like this

Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.

View original filing